Oxanine Aptamer Site-Specific Polypeptide Conjugation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional bioconjugate methods face challenges in achieving site-specific and efficient attachment of synthetic molecules to proteins, leading to heterogeneous mixtures and unpredictable pharmacokinetics, safety, and efficacy profiles in antibody-drug conjugates due to non-specific conjugation to active sites.
Innovation Solution
The use of aptamers containing oxanine, which specifically recognize polypeptides and react with amine groups to form amide bonds, allowing for site-specific conjugation of drugs or labels to polypeptides without chemical or genetic modification, using a lock-and-key binding and proximity-enhanced reaction mechanism.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional bioconjugate methods are used to attach synthetic molecules to proteins, then the conjugation process is simple, but the conjugation is non-specific leading to heterogeneous mixtures and unpredictable pharmacokinetics
Solution Approach 1:
The patent introduces an aptamer as an intermediary molecule that specifically binds to the target protein and recruits the synthetic molecule to the desired site. This mediator enables site-specific conjugation without requiring complex genetic modification or chemical treatment of the protein, thus improving manufacturing precision while keeping the method relatively simple.
Solution Approach 2:
The aptamer is designed to pre-bind to the target protein at the specific site before the synthetic molecule is introduced. This preliminary binding action ensures that when the synthetic molecule is added, it is recruited to the correct location, achieving site-specific conjugation without complex procedures.
2Manufacturing precision
If genetic modification or chemical treatment is used to achieve site-specific conjugation, then the conjugation specificity is improved, but the process complexity and pretreatment requirements increase
Solution Approach 1:
The aptamer serves as a mediator that achieves site-specific conjugation without requiring genetic modification or chemical treatment of the target protein. The aptamer naturally binds to the protein at the desired site and recruits the synthetic molecule, eliminating complex pretreatment steps while maintaining high conjugation specificity.
Solution Approach 2:
The aptamer autonomously binds to the target protein at the specific site and facilitates the conjugation process without requiring external modification of the protein. The system uses the aptamer's natural binding properties to achieve site-specific conjugation, eliminating the need for pretreatment processes.
3Reliability
If conventional conjugation methods are used, then the process is straightforward, but the location of drug attachment is non-specific affecting pharmacokinetics and safety
Solution Approach 1:
The aptamer acts as a mediator that ensures the synthetic molecule is attached at a specific, predictable location on the target protein. This site-specific attachment leads to consistent pharmacokinetic properties and predictable safety profiles, improving reliability while the aptamer-based system maintains reasonable complexity.
4Manufacturing precision
If site-specific conjugation is achieved through genetic modification, then the conjugation precision is improved, but the time and resources required for pretreatment increase
Solution Approach 1:
The aptamer serves as a mediator that achieves site-specific conjugation without requiring time-consuming genetic modification or chemical treatment. The aptamer can be synthesized independently and then used to bind to the target protein and recruit the synthetic molecule, achieving high precision conjugation more quickly than genetic modification approaches.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the formation of stable, homogeneous conjugates with high specificity and efficiency, maintaining the original functions of the polypeptide and enhancing therapeutic efficacy and safety by ensuring precise drug attachment to specific sites on polypeptides.
Implementation Method 1
using a lock-and-key binding and proximity-enhanced reaction mechanism
Implementation Method 2
react with amine groups to form amide bonds
Implementation Method 3
react with amine groups to form amide bonds
Implementation Method 4
using a lock-and-key binding and proximity-enhanced reaction mechanism
Data Source
AI summary
The present invention relates to a preparation of a polypeptide conjugate using an aptamer containing oxanine. In particular, the present invention relates to a composition for preparing a conjugate of a polypeptide, the composition comprising an aptamer containing oxanine, and a method of preparing a conjugate of a polypeptide using the same. The present invention also relates to a conjugate comprising a polypeptide and an aptamer containing oxanine, and a conjugate comprising a polypeptide and a drug.